TFF Pharmaceuticals announced the appointment of Michael Patane, Ph.D., to its Board of Directors. Most recently, Mike served as President of Mitobridge.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TFFP:
- TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
- TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023
- TFF Pharmaceuticals files $100M mixed securities shelf
- TFF Pharmaceuticals price target lowered to $9 from $12 at Roth MKM
- TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update